Sign in
4

Changes in Ownership

Sionna Therapeutics, Inc. Filed Acc 0002046433-26-000005

CMO and Head of R&D acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

McKee Charlotte · CMO and Head of R&D

Table I: Non-derivative

2 lines
Date Transaction Shares Owned after D/I
2026-09-17 Grant or award : show line 1 in the form +50,000 78,415 D
2026-09-17 Grant or award : show line 2 in the form +50,000 128,415 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-09-17 Grant or award : show line 3 in the form Non-Qualified Stock Option (right to buy) +155,700 155,700 D
2026-09-17 Returned to the company : show line 4 in the form Non-Qualified Stock Option (right to buy) −155,700 0 D
Loading xslF345X06/edgardoc.xml…